4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-25-088878
Director sold 2,405 shares at $37.39 ($89,923)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Sanders Corazon (Corsee) D. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-20 | Sale : show line 1 in the form 10b5-1 | −2,405 | $37.39 | $89,923 | 15,344 | D |
| Open-market sales · 2,405 sh · avg $37.39 · $89,923 | ||||||
Loading xslF345X05/ownership.xml…